PUTRAJAYA, March 21 (Bernama) — Sponsored clinical research in Malaysia recorded an exceptional performance in 2021, surpassing its previous years accomplishments, as highlighted in Clinical Research Malaysia’s (CRM) Annual Report 2021. The report was launched earlier today by the Minister of Health, YB Khairy Jamaluddin at the Ministry of Health complex in Putrajaya, witnessed by CRM Board of Directors and stakeholders.
The annual report detailed 215 new sponsored clinical research in the country, the highest annual number reported since CRM’s inception. In 2021, Malaysia moved a position up, now ranking second within Southeast Asia region after Singapore, in terms of the number of global industry sponsored studies. These record-high numbers were also reflected in the Gross National Income generated, with highest annual value of RM 226 million investment reported from new sponsored studies, contributing to a cumulative value of RM 834 million generated from sponsored research since 2012.
- US completes deportation of 8 men to South Sudan after weeks of legal wrangling
- Iran’s Supreme Leader Attended Mourning Ceremony In Tehran
- Zionist Israeli Army Claims Control Of 65 Percent Of Gaza; Death Toll: 57,130+ Palestinians
- Brazil: Rio de Janeiro gears up for BRICS Summit
- DR Congo gov’t, M23 rebels to hold new round of talks in Doha: AFC official
- Bangladesh Ready To Cooperate With Malaysia In Terror Investigation
- 45 Opposition Party Members In Türkiye’s Izmir Arrested On Corruption Charges
- Iran Reaffirms Commitment To Diplomacy, Urges Reciprocal Action
- DPRK Condemned Denuclearisation Calls By U.S.-Led Quad
- S. Korea’s Parliament Approves Prime Minister Nominee